aXichem AB (FRA:A6X) ROE % Adjusted to Book Value: -16.67% (As of Mar. 2026)


FRA:A6X aXichem AB FRA:A6X
65 GF Score
Price €0.18
GF Value €0.27
View Full Analysis

What is aXichem AB ROE % Adjusted to Book Value?

aXichem AB FRA:A6X -15.14% 65 ROE % Adjusted to Book Value is -16.67% as of Mar. 2026. GuruFocus rates FRA:A6X with a GF Score™ of 65/100 and a GF Value™ of €0.27.

aXichem AB's ROE % for the quarter that ended in Mar. 2026 was -20.67%. aXichem AB's PB Ratio for the quarter that ended in Mar. 2026 was 1.24. aXichem AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -16.67%.


aXichem AB ROE % Adjusted to Book Value Related Terms


aXichem AB ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for aXichem AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aXichem AB ROE % Adjusted to Book Value Chart

aXichem AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.72 -5.96 -26.27 -39.59 -15.33

aXichem AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.78 -9.37 -6.95 -19.84 -16.67

FRA:A6X vs LIN, SHW, ECL: ROE % Adjusted to Book Value Comparison

For the Specialty Chemicals subindustry, aXichem AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aXichem AB ROE % Adjusted to Book Value vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, aXichem AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where aXichem AB's ROE % Adjusted to Book Value falls into.


FRA:A6X
65GF Score
aXichem AB FRA:A6X
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aXichem AB ROE % Adjusted to Book Value Calculation

aXichem AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-29.58% / 1.93
=-15.33%

aXichem AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-20.67% / 1.24
=-16.67%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -16.67% mean?
aXichem AB (FRA:A6X) has a ROE % Adjusted to Book Value of -16.67% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on aXichem AB and its competitors.
Is aXichem AB's ROE % Adjusted to Book Value too high?
aXichem AB's current ROE % Adjusted to Book Value is -16.67%. Overall, aXichem AB has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's ROE % Adjusted to Book Value compare to LIN and SHW?
aXichem AB's ROE % Adjusted to Book Value of -16.67% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Chemicals company?
A good ROE % Adjusted to Book Value depends on the Chemicals industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on aXichem AB and its competitors. aXichem AB's current ROE % Adjusted to Book Value is -16.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
aXichem AB (FRA:A6X) has a current ROE % Adjusted to Book Value of -16.67%. The stock's GF Value™ is €0.27, compared to a current price of €0.18 — trading 34.6% below its estimated fair value. The current ROE % Adjusted to Book Value is -16.67%. aXichem AB's overall GF Score™ is 65/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For aXichem AB (FRA:A6X), the current ROE % Adjusted to Book Value is -16.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aXichem AB (FRA:A6X) Overvalued in 2026?

Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued. The current stock price of €0.18 is trading 34.6% below its estimated GF Value™ of €0.27.

Key valuation signals for FRA:A6X:

  • ROE % Adjusted to Book Value: -16.67%
  • GF Value™: €0.27 vs. price of €0.18 (34.6% below fair value)
  • GF Score™: 65/100

No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


aXichem AB Business Description

Other Exchanges AXIC A:Sweden
Address Sodergatan 26, Malmo, NOR, 211 34
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
65GF Score

Get the complete analysis for FRA:A6X

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.18
Price
€0.27
GF Value